Current Molecular Medicine
Title:Editorial (Hot Topic:Human Pluripotent Stem Cells in Regenerative and Personalized Medicine)
Volume: 13 Issue: 5
Author(s): Thomas Dittmar and Michael Rossbach
Affiliation:
Export Options
About this article
Cite this article as:
Dittmar Thomas and Rossbach Michael, Editorial (Hot Topic:Human Pluripotent Stem Cells in Regenerative and Personalized Medicine), Current Molecular Medicine 2013; 13 (5) . https://dx.doi.org/10.2174/1566524011313050001
DOI https://dx.doi.org/10.2174/1566524011313050001 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epidemiology and Management of Acute Kidney Injury in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
Current Protein & Peptide Science Emergence of Three Dimensional Printed Cardiac Tissue: Opportunities and Challenges in Cardiovascular Diseases
Current Cardiology Reviews RCAN1 Increases Aβ Generation by Promoting N-glycosylation via Oligosaccharyltransferase
Current Alzheimer Research Role of Hydrogen in Atherosclerotic Disease: From Bench to Bedside
Current Pharmaceutical Design Editorial [ Proteases and Phospholipases in CNS Disorders Guest Editor: Swapan K. Ray ]
CNS & Neurological Disorders - Drug Targets Regulation of Cholesterol Biosynthesis and Absorption: Ultimate Management of Dyslipidemia with Statin and Ezetimibe
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Adenosine in the Central Nervous System: Effects on Neurotransmission and Neuroprotection
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) A Review of Recent Patents (2016-2019) on Plant Food Supplements with Potential Application in the Treatment of Neurodegenerative and Metabolic Disorders
Recent Patents on Food, Nutrition & Agriculture Huntingtons Disease: The Value of Transcranial Meganetic Stimulation
Current Medicinal Chemistry The Epidemiology of Sepsis
Current Pharmaceutical Design The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) Transplantation of Stem Cells as a Potential Therapeutic Strategy in Neurodegenerative Disorders
Current Stem Cell Research & Therapy The Impact of Diabetes Mellitus on Coronary Artery Disease: New Therapeutic Approaches
Current Pharmaceutical Design Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells
Current Pharmaceutical Design Editorial [Hot Topic “Fluorescent Probes: From Bench to Bedside” (Guest Editors: Enza Lacivita & Marcello Leopoldo)]
Current Medicinal Chemistry In Vivo Electroporation of Gene Sequences for Therapeutic and Vaccination Applications
Recent Patents on DNA & Gene Sequences Updated Understanding of Platelets in Thrombosis and Hemostasis: The Roles of Integrin PSI Domains and their Potential as Therapeutic Targets
Cardiovascular & Hematological Disorders-Drug Targets The Frequency and Risk Factors of Diabetic Foot Ulcer Recurrence Among Jordanian Patients with Diabetes
Current Diabetes Reviews Treatment of Diabetic Foot Ulcers
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Dyslipidemia Management in 2020: An Update on Diagnosis and Therapeutic Perspectives
Endocrine, Metabolic & Immune Disorders - Drug Targets